amg-820
mAbexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2008 (NCT01444404)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
CSF1R inhibitor
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2109322 ↗
Also known as
- amg820
- amg 820
- amg-820
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02713529 | Phase 1/Phase 2 (Phase 2) | Apr 14, 2016 | Amgen, Merck |
| NCT01444404 | Phase 1 | Mar 1, 2008 | Amgen |
Showing 2 of 2 trials
Page 1 / 1